×
About 840 results

ALLMedicine™ C-terminal Telopeptide Center

Research & Reviews  286 results

Individualized high dairy protein + walking program supports bone health in pregnancy: ...
https://doi.org/10.1093/ajcn/nqac182
The American Journal of Clinical Nutrition; Perreault M, Mottola MF et. al.

Jun 28th, 2022 - Pregnancy induces bone mineral mobilization, which may be further compromised if diet and physical activity are sub-optimal. We aimed to determine the effects of a Nutrition + Exercise intervention during pregnancy on maternal calciotropic and bon...

Bone Turnover Marker Profiling and Fracture Risk in Older Women: Fracture Risk from Age...
https://doi.org/10.1007/s00223-022-00996-8 10.1007/s11657-020-00871-9 10.1373/clinchem.2004.043901 10.1373/clinchem.2005.055541 10.1515/CCLM.2011.602 10.1007/s00223-014-9842-y 10.1359/JBMR.0301244 10.1359/jbmr.091006 10.1016/S2213-8587(17)30184-5 10.1007/s00198-010-1501-1 10.1007/s12020-016-0900-2 10.1016/S8756-3282(00)00325-2 10.1359/jbmr.2000.15.8.1526 10.1359/JBMR.041207 10.1210/jc.2006-2079 10.1136/ard.2007.077941 10.1359/jbmr.090526 10.1007/s00198-012-2106-7 10.1210/jc.2014-2646 10.1016/j.bone.2015.06.016 10.1007/s00198-014-2823-1 10.1302/0301-620X.89B12.18946 10.3109/17453674.2014.920987 10.1007/s00198-014-2951-7 10.1136/jech.48.5.489 10.1007/s00198-007-0543-5 10.1093/clinchem/46.3.332 10.1530/EC-15-0022 10.1515/cclm-2012-0531 10.1002/jbmr.2017 10.1016/j.jocd.2017.06.020 10.1210/jc.2015-3951 10.1002/jbmr.3471 10.1007/s00198-019-05043-1 10.1210/jc.2010-2878 10.1002/jbmr.3953 10.1007/s00198-012-2048-0 10.1002/jbmr.5650111021 10.1530/EJE-17-0585 10.1007/s11914-011-0059-y 10.1007/s11914-013-0158-z 10.1007/s00198-017-3976-5 10.1210/jc.2007-1508 10.1007/s00774-004-0537-8 10.1016/j.bone.2005.02.009
Calcified Tissue International; Ivaska KK, McGuigan FE et. al.

Jun 25th, 2022 - A major challenge in osteoporosis is to identify individuals at high fracture risk. We investigated six bone turnover markers (BTMs) to determine association with specific fracture types; the time-frame for risk prediction and whether these are in...

Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-Oophorectomy
https://clinicaltrials.gov/ct2/show/NCT03382574

Jun 14th, 2022 - PRIMARY OBJECTIVE: I. To compare the effect of denosumab 120 mg subcutaneously every 4 weeks for 1-2 doses to no treatment in the pre-surgical setting on Ki67 proliferation index by immunohistochemistry (IHC) in the fimbrial end of the fallopian t...

Changes in sex steroids and enteric peptides after sleeve gastrectomy in youth in relat...
https://doi.org/10.1210/clinem/dgac361
The Journal of Clinical Endocrinology and Metabolism; Nimmala S, Kaur S et. al.

Jun 12th, 2022 - Sleeve gastrectomy (SG) improves metabolic endpoints but is associated with impaired bone outcomes. To determine mechanisms contributing to impaired bone health in youth following SG. 12-month longitudinal observational study. Multi-disciplinary t...

One-Year Mean A1c of > 7% is Associated with Poor Bone Microarchitecture and Strength i...
https://doi.org/10.1007/s00223-022-00993-x 10.1016/j.diabres.2019.107843 10.1359/jbmr.2003.18.4.784 10.1210/jc.2008-0639 10.1359/JBMR.040311 10.2147/TCRM.S131945 10.1002/jbmr.3002 10.2337/dc06-0440 10.1007/s001250051248 10.1007/s00198-006-0253-4 10.2105/AJPH.79.3.274 10.1093/oxfordjournals.aje.a116756 10.1016/j.bone.2017.03.039 10.1038/nrendo.2016.153 10.1016/j.bone.2015.07.027 10.1111/joim.12725 10.1007/s00198-005-1877-5 10.1185/03007990902801147 10.1210/jc.2010-0226 10.1002/jbmr.2106 10.1002/jbmr.2388 10.1002/jbmr.3240 10.1371/journal.pone.0035047 10.1016/S8756-3282(00)00434-8 10.1016/j.bone.2005.07.019 10.1186/s13098-017-0278-1 10.1186/s12902-017-0224-0 10.1038/boneres.2016.1 10.1210/jc.2012-1546 10.2337/dc12-1188 10.1002/jbmr.2462 10.1210/jendso/bvab048.560 10.1016/S0140-6736(98)07019-6 10.1016/S0140-6736(98)07037-8 10.2337/dc21-S006 10.3389/fendo.2020.00277 10.1210/clinem/dgab061 10.1210/js.2019-MON-094 10.1016/j.conctc.2021.100723 10.1038/ijir.2009.35 10.7573/dic.212607 10.1530/EJE-14-1103 10.1002/jbmr.2176 10.1002/jbmr.297 10.1016/S8756-3282(02)00736-6 10.1210/jc.2018-00229 10.1053/j.gastro.2007.04.068 10.1055/s-2006-923886 10.1038/nrendo.2017.151 10.1001/jama.295.11.1288 10.3389/fphys.2014.00137 10.1002/jcb.10220 10.1016/S8756-3282(02)00866-9 10.1002/jbmr.3057 10.1002/jbmr.3711 10.1016/j.bone.2017.05.004 10.1016/j.jbiomech.2007.09.003 10.1016/j.jbiomech.2018.11.030 10.1016/j.diabres.2016.03.009 10.1111/j.1532-5415.2012.04052.x
Calcified Tissue International; Ballato E, Deepika FNU et. al.

Jun 7th, 2022 - Type 2 diabetes mellitus (T2DM) is associated with normal or slightly elevated bone mineral density (BMD) but paradoxically increased fracture risk. Although multiple mechanisms have been proposed to explain this observation, one thing is clear fr...

see more →

Guidelines  1 results

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY...
https://doi.org/10.4158/EP161435.GL
Endocrine Practice : Official Journal of the American Col... Camacho PM, Petak SM et. al.

Sep 24th, 2016 - AACE = American Association of Clinical Endocrinologists AFF = atypical femur fracture ASBMR = American Society for Bone and Mineral Research BEL = best evidence level BMD = bone mineral density BTM = bone turnover marker CBC = complete blood coun...

see more →

Clinicaltrials.gov  33 results

Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-Oophorectomy
https://clinicaltrials.gov/ct2/show/NCT03382574

Jun 14th, 2022 - PRIMARY OBJECTIVE: I. To compare the effect of denosumab 120 mg subcutaneously every 4 weeks for 1-2 doses to no treatment in the pre-surgical setting on Ki67 proliferation index by immunohistochemistry (IHC) in the fimbrial end of the fallopian t...

Averting Complications of Proton Pump Inhibitor Therapy by Effervescent Calcium Magnesium Citrate
https://clinicaltrials.gov/ct2/show/NCT03812380

Jun 1st, 2022 - In a single-dose bioavailability study, the investigators showed previously that provision of calcium and magnesium in a soluble form as EffCaMgCit improved intestinal absorption of calcium and magnesium and suppressed parathyroid function during ...

Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.
https://clinicaltrials.gov/ct2/show/NCT03958565

May 13th, 2022 - This is an observational study involving two arms of NSCLC with metastatic bony disease at the time of enrollment in the study. One group will have an actionable driver oncogene and initiate treatment in any line with a TKI as standard of care and...

Bone Microarchitecture in Men With Hemophilia
https://clinicaltrials.gov/ct2/show/NCT05127681

Mar 9th, 2022 - Hemophilia A and B are hereditary sex-linked deficiencies of coagulation factors VIII and IX characterized by bleeding. Their modern therapy increases life expectancy and risk of age-related diseases, e.g., osteoporosis. Hemophilia-specific risk f...

Combined Drug Therapy in Lateral Fragility Fractures of the Femur
https://clinicaltrials.gov/ct2/show/NCT05183308

Feb 4th, 2022 - It was conducted a prospective study with a series of 50 patients treated by intramedullary nail using Clodronic acid and Vitamin D (study group including 25 patients) and patients with the same fractures treated with Vitamin D alone (control grou...

see more →

News  16 results

Hopes Dashed for Novel Osteoarthritis Treatment
https://www.medpagetoday.com/rheumatology/arthritis/97548

Mar 8th, 2022 - A promising therapy aimed at halting and even reversing the pathology underlying osteoarthritis (OA) of the knee failed to show any benefit in a randomized trial. Neither clinical nor radiographic outcomes differed between patients who received pu...

Lumbar Epidural Steroid Jab Lowers Bone Formation in Older Women
https://www.medscape.com/viewarticle/960948

Oct 15th, 2021 - Among postmenopausal women who received an epidural steroid injection (ESI) in the lumbar spine to treat back and leg pain arising from a compressed nerve in the spine, levels of bone formation biomarkers were decreased. The decrease in levels per...

Less Frequent Zoledronic Acid Not Linked to Increased Skeletal Events for Patients With Bone Metastases
https://www.onclive.com/view/less-frequent-zoledronic-acid-not-linked-to-increased-skeletal-events-for-patients-with-bone-metastases

Nov 13th, 2020 - Andrew L. Himelstein, MD Among patients with bone metastases due to breast cancer, prostate cancer, or multiple myeloma, those who used zoledronic acid every 12 weeks, compared with the standard dosing interval of every 4 weeks, did not experienc...

Denosumab Favored Over Alendronate for BMD Protection in Glucocorticoid-Induced Osteoporosis
https://www.medscape.com/viewarticle/940923

Nov 13th, 2020 - Denosumab boosted bone mineral density (BMD) over 12 months to a greater extent than did alendronate in a randomized, 12-month study. The investigator-initiated research compared BMD at the lumbar spine and elsewhere among people with systemic lup...

Treatment Sequence With Romosozumab Influences Osteoporosis Outcomes
https://www.staging.medscape.com/viewarticle/940675

Nov 10th, 2020 - Timing is everything when it comes to the use of the anabolic agent romosozumab (Evenity) for the treatment of advanced osteoporosis, a review of clinical trials suggests. In four studies with treatment sequences in which romosozumab was administe...

see more →